Drupal.behaviors.print = function(context) {window.print();window.close();}>
Duke Team IDs Warburg Effect and Linked Proteins as Possible Breast Cancer Predictor, Drug Target
September 30, 2011
Duke Team IDs Warburg Effect and Linked Proteins as Possible Breast Cancer Predictor, Drug Target
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Duke Team Identifies Phosphoprotein Signatures That Could Predict Breast Cancer Risk
November 12, 2010 / ProteoMonitor
Theranostics Looks for Med Fusion Deal to Aid in Clinical Validation, Payor Access
August 31, 2012 / ProteoMonitor
UNC Team Takes Proteomic Approach to Study Drug Resistance in Triple-Negative Breast Cancer
April 20, 2012 / ProteoMonitor
Florida Licenses Provista Dx for Clinical Lab Services
May 7, 2013 / GenomeWeb Daily News
Theranostics Health to Launch HER Signaling Assay, Marking Firm's First Commercial Test Release
May 3, 2013 / ProteoMonitor